Skip to main content
Caplight Logo









Axoft

Axoft

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://axoft.us

Last Round

Series A

Apr 29, 2026

Est. Valuation

$33M

Total Funding Raised

$63M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Axoft operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series A round in April 2026.

Axoft is a neurotechnology company that develops implantable Brain-Computer Interfaces (iBCIs) using novel, ultra-soft materials to treat neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Data as a Service, Services & Consulting, Government Contracts

AI Layer

Foundation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Axoft Comparables

Compare Axoft with similar companies based on industry and business-model similarity.

Axoft comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
INBRAIN Neuroelectronics
84%
NeuroXess
82%
Neurosoft Bioelectronics
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Axoft Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 29, 2026
SeedOct 18, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Axoft Investors

Notable investors and investment history

Axoft investors
InvestorRounds
Blindspot VenturesSeed
Engine VenturesSeed
Hillhouse InvestmentSeries A
Project 11 VenturesSeed
Taihill VentureSeed
Stanford UniversitySeries A
Reform VenturesSeed
Book a demo to see all 20 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 79% MoM, reaching 6.5K.

  • Jul 1, 2026

    Developing next-generation ultrasoft stimulation electrodes.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • is_developingNov 4, 2026

    Axoft, Inc. is building implantable brain-computer interfaces (iBCIs) that use bio-inspired materials to enable seamless brain-electronics interfaces and high-resolution measurement and stimulation across brain regions in Massachusetts.

  • launchesAug 28, 2026

    Axoft, Inc. formally launches its Fleuron-based materials portfolio in 2025 and uses custom Fleuron formulations in implantable brain-computer interface devices to support biocompatibility, long-term signal stability, and high-bandwidth communication between the brain and electronics.

  • launchesAug 25, 2026

    Axoft, Inc. introduces Fleuron(R) WISE, a UV-curable polymer engineered to disappear in water and enable sharper, higher-resolution imaging for aqueous samples, in Massachusetts on Aug 25th '26.

Book a demo to see all news

For institutional investors. Book with your work email.

Axoft Filings

Explore SEC and related filing metadata, where available.

Axoft filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Axoft's valuation, stock price, and market status.

Is Axoft a public or private company?

Axoft is a private company.

What is the current stock price of Axoft?

Axoft is a private company, so its shares have no public market price. Caplight tracks Axoft's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Axoft worth (valuation)?

Axoft's valuation is estimated at $33.0M based on funding round data.

Can I buy Axoft stock?

Axoft shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Axoft's last funding round?

Axoft's most recent funding round was Series A on April 29, 2026.

Who are the main investors in Axoft?

Key investors in Axoft include Engine Ventures, Engine Ventures, C.P. Group Innovation.

Will Axoft IPO soon?

No public IPO plans have been announced for Axoft.

How can I track Axoft secondary market activity?

Caplight tracks bids, offers, and trades in Axoft's shares on secondary markets.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range36
Year Founded2021
Last FundingApr 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?